TC BioPharm (Holdings) plc

1.07 USD
-0.05 (-4.46%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

TC BioPharm (Holdings) plc stock is down -6.96% since 30 days ago. The next earnings date is Jun 25, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 June’s closed higher than May.

About TC BioPharm (Holdings) plc

TC Biopharm (Holdings) Plc focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia.